Lupus Science & Medicine: 10 (1)

Animal models

Original research: Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse (24 April, 2023)
Shuzo Sato, Xian K Zhang, Naoki Matsuoka, Yuya Sumichika, Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Tomoyuki Asano, Kiyoshi Migita
Original research: Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr mice (11 April, 2023)
Xin Zhang, Juan Meng, Xuhua Shi, Robert James Quinet, William Davis, Jerald Zakem, Chandana Keshavamurthy, Ronak Patel, Gitanjali Lobo, Linh Hellmers, Alicia Nicole Ray, Laura E Rivers, Hiba Ali, Therese Posas-Mendoza, Chad Hille, Zongbing You

Brief communication

Genetic load in incomplete lupus erythematosus (4 January, 2023)
Matt Slief, Joseph M Kheir, Miles Smith, Colin Mowery, Susan Macwana, Wade DeJager, Catriona A Wagner, Teresa Aberle, Judith A James, Joel M Guthridge

Co-morbidities

Original research: Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE (3 March, 2023)
Stylianos Panopoulos, George C Drosos, George Konstantonis, Petros P Sfikakis, Maria G Tektonidou
Original research: Clinical associations of cognitive dysfunction in systemic lupus erythematosus (28 February, 2023)
Sudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, Rangi Kandane-Rathnayake, Eric F Morand, Julie C Stout, Alberta Hoi
Original research: Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus (14 February, 2023)
Sebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H Giordano, Maria E Suarez-Almazor

Childhood lupus

Original research: Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE (30 May, 2023)
Ellen M Cody, Bridget E Wilson, Ekemini A Ogbu, Jennifer L Huggins, Chen Chen, Tingting Qiu, Tracy V Ting, Francisco Flores, Bin Huang, Hermine I Brunner
Original research: Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus (3 April, 2023)
Shengfang Bao, Hua Huang, Yingying Jin, Fei Ding, Zhen Yang, Xuemei Xu, Chenxi Liu, Jingyi Lu, Yanliang Jin
Original research: Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study (3 April, 2023)
Mohamed Javad Wahadat, Sander J van Tilburg, Yvonne M Mueller, Harm de Wit, Cornelia G Van Helden-Meeuwsen, Anton W Langerak, Marike J Gruijters, Amani Mubarak, Marleen Verkaaik, Peter D Katsikis, Marjan A Versnel, Sylvia Kamphuis

Cutaneous lupus

Original research: Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China (20 March, 2023)
Hui Jin, Shihang Zhou, Yangyiyi Yu, Ming Zhao, Haijing Wu, Hai Long, Siqi Fu, Ruifang Wu, Heng Yin, Jieyue Liao, Shuangyan Luo, Yu Liu, Qing Zhang, Peng Zhang, Yixin Tan, Shuaihantian Luo, Xin Huang, Fen Li, Guanghui Ling, Qianjin Lu

Epidemiology and outcomes

Original research: Gender differences in SLE: report from a cohort of 417 Caucasian patients (25 April, 2023)
Francesca Trentin, Viola Signorini, Maria Laura Manca, Giancarlo Cascarano, Luca Gualtieri, Davide Schilirò, Anastasiya Valevich, Chiara Cardelli, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Stagnaro, Dina Zucchi, Chiara Tani, Marta Mosca
Original research: Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample (5 April, 2023)
Rashmi Dhital, Monica Guma, Dilli R Poudel, Christina Chambers, Kenneth Kalunian
Original research: Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE (3 April, 2023)
Anca D Askanase, Wei Tang, Qing Zuraw, Robert Gordon, Betsy Brotherton, Joan T Merrill
Original research: A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort (14 February, 2023)
Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón
Original research: Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study (3 February, 2023)
Rory C Monahan, Liesbeth J J Beaart-van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A M Middelkoop, Gisela M Terwindt, Nic J A van der Wee, Tom W J Huizinga, Gerda M Steup-Beekman

Genetics

Original research: B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children (18 May, 2023)
Joyce Hui-Yuen, Kaiyu Jiang, Susan Malkiel, Barbara Anne Eberhard, Heather Walters, Betty Diamond, James Jarvis

Immunology and inflammation

Original research: Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks (5 May, 2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew
Original research: Molecular endotypes of type 1 and type 2 SLE (30 January, 2023)
Robert Robl, Amanda Eudy, Prathyusha S Bachali, Jennifer L Rogers, Megan Clowse, David Pisetsky, Peter Lipsky
Original research: Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus (11 January, 2023)
Serena Fasano, Valentina Messiniti, Michele Iudici, Melania Alessia Coscia, Francesco Ciccia

Letter

Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later (25 January, 2023)
Alain Cornet, Jeanette Andersen, Chiara Tani, Marta Mosca

Lupus nephritis

Original research: Remission of lupus nephritis: the trajectory of histological response in successfully treated patients (31 May, 2023)
Ana Malvar, Valeria Alberton, Bruno Lococo, Maria Lourenco, Joaquin Martinez, Lucrecia Burna, Celeste Besso, Jordi Navarro, Haikady N Nagaraja, Aastha Khatiwada, Bethany Wolf, Brad Rovin
Original research: Glomerular mTORC1 activation was associated with podocytes to endothelial cells communication in lupus nephritis (5 May, 2023)
Xiaotian Liu, Zhaomin Mao, Mo Yuan, Linlin Li, Ying Tan, Zhen Qu, Min Chen, Feng Yu
Original research: Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis (30 January, 2023)
Ahmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gábor G Illei, S Sam Lim, Wendy I White
Original research: Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials (13 January, 2023)
Ian N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala

Meeting report

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective (14 February, 2023)
Joy Buie, Lauren Bloch, Eric F Morand, Ronald F van Vollenhoven, Victoria P Werth, Zahi Touma, Peter Lipsky, Kenneth Kalunian, Anca D Askanase, L Ines, Christopher Reed, MaryBeth Son, Timothy Franson, Karen Costenbader, Laura Eve Schanberg
Lupus spectrum ambiguity has long-term negative implications for patients (11 January, 2023)
Ian N Bruce, Joy Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Roger A Levy, Victoria P Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi

Review

Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives (22 February, 2023)
Eya Toumi, Soraya Mezouar, Anne Plauzolles, Laurent Chiche, Nathalie Bardin, Philippe Halfon, Jean Louis Mege

Short report

Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data (24 March, 2023)
David D'Cruz, Gina Eriksson, Yulia Green, Anne Hammer, Beulah Ji, Paige Meizlik, David A Roth
Pacritinib abrogates the lupus phenotype in ABIN1[D485N] mice (23 February, 2023)
Tsvetana Petrova, Clara Figueras-Vadillo, Sambit K Nanda, Cheryl Scudamore, Philip Cohen

Main menu

Table of contents

2023 - Volume 10 - 1

Animal models

Brief communication

Co-morbidities

Childhood lupus

Cutaneous lupus

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter

Lupus nephritis

Meeting report

Review

Short report

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

2023 - Volume 10 - 1

Animal models

Brief communication

Co-morbidities

Childhood lupus

Cutaneous lupus

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter

Lupus nephritis

Meeting report

Review

Short report